View Clinical Trial (Medical Research Study)
Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients - NCT00454922-80045(Clinical Trial 167206)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Aurora |
|
State:
|
|
CO |
| Zip Code: |
|
80045 |
| Conditions: |
|
Glaucoma |
| Purpose: |
|
Glaucoma is a leading cause of blindness worldwide. Non-adherence to glaucoma medication,
which may result in loss of vision, is known to be prevalent. Available information
regarding adherence to prescribed medical therapy suggests that some apparent treatment
failures may actually be due to non-adherence. The investigators' specific aim is to conduct
a study that will examine the effect of a glaucoma educator intervention on adherence to
topical glaucoma therapy. The investigators' hypothesis is that patient education and
counseling delivered by a trained glaucoma educator, through both planned visits and
telephone contacts, will increase adherence to topical glaucoma therapy.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Diagnosis of primary or secondary open angle glaucoma.
- Currently on monotherapy drop treatment for glaucoma.
- Age > 18 years.
- Patient has presented for care at the Rocky Mountain Lions Eye Institute Glaucoma
Center.
Exclusion Criteria:
- Inability to independently administer eye drops due to physical disability as
reported by the patient.
- Cognitive impairment that would interfere with the ability to self-administer
medications as evidenced by a TICS score < 16.
- Patients who demonstrate > 80% adherence to glaucoma treatment during the 30 day
run-in period.
- It is anticipated that the patient will require glaucoma surgery within the next six
months. |
|
|
|
| Study is available at: |
|
Rocky Mountain Lions Eye Institute Aurora, CO 80045 United States
Primary Contact: Mary Preston Email: mary.preston@ucdenver.edu Phone: 720-848-2035
Secondary Contact: Mary Preston Email: mary.preston@ucdenver.edu Phone: 720-848-2035 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|